Article révisé par les pairs
Titre:
  • A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
Auteur:Demotte, Nathalie; Wieërs, Grégoire; Van Der Smissen, Patrick; Moser, Muriel; Schmidt, Christopher; Thielemans, Kris M.; Squifflet, Jean-Luc; Weynand, Birgit; Carrasco, Javier; Lurquin, Christophe; Courtoy, Pierre; van der Bruggen, Pierre
Informations sur la publication:Cancer research, 70, 19, page (7476-7488)
Statut de publication:Publié, 2010-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Amino Sugars -- pharmacology
Animals
Ascites -- immunology -- pathology
Breast Neoplasms -- immunology -- pathology -- therapy
CD4-Positive T-Lymphocytes -- drug effects -- immunology
CD8-Positive T-Lymphocytes -- drug effects -- immunology
Cancer Vaccines -- immunology -- pharmacology
Cell Line, Tumor
Female
Galectin 3 -- immunology
Humans
Interferon-gamma -- immunology -- secretion
Ligands
Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology
Mastocytoma -- drug therapy -- immunology
Melanoma -- immunology -- pathology -- therapy
Mice
Neoplasms -- drug therapy -- immunology -- therapy
Pleural Effusion, Malignant -- immunology -- pathology
Polysaccharides -- pharmacology
Receptors, Antigen, T-Cell -- immunology
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0008-5472
info:doi/10.1158/0008-5472.CAN-10-0761
info:pii/0008-5472.CAN-10-0761
info:scp/77957355951
info:pmid/20719885

Documents en relation

DI-fusion